SCHEMBL14120773

SCHEMBL14120773

COc1ccc(-c2cccc(S(=O)(=O)Cl)c2)c(OC)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 2/20 0.67
▸ CYP1A2 P05177 2/20 0.67
▸ CYP3A4 P08684 2/20 0.67
▸ CYP1B1 Q16678 2/20 0.67
▸ CYP2E1 P05181 1/20 0.67
▸ CYP2C8 P10632 1/20 0.67
▸ CYP2D6 P10635 1/20 0.67
▸ CYP2A6 P11509 1/20 0.67
▸ CYP2C9 P11712 1/20 0.67
▸ CYP4B1 P13584 1/20 0.67
▸ CYP2B6 P20813 1/20 0.67
▸ CYP3A5 P20815 1/20 0.67
▸ CYP2A7 P20853 1/20 0.67
▸ CYP3A7 P24462 1/20 0.67
▸ CYP2F1 P24903 1/20 0.67
▸ CYP2C18 P33260 1/20 0.67
▸ CYP2C19 P33261 1/20 0.67
▸ CYP2J2 P51589 1/20 0.67
▸ CYP4F2 P78329 1/20 0.67
▸ CYP4F8 P98187 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14120619 0.84 KAT6A (0.53) CYP1A1CYP1A2CYP3A4CYP1B1CYP2E1
SCHEMBL14121066 0.84 PLAU (0.55) CYP1A1CYP1A2CYP3A4CYP1B1CYP2E1
SCHEMBL14120564 0.82 PTGES2 (0.52) CYP1A1CYP1A2CYP3A4CYP1B1CYP2E1
SCHEMBL788413 0.80 ABL1 (0.54) LMNAHDAC4HDAC2HDAC8PLAU
SCHEMBL31058811 0.79 CA12 (0.49) CYP1A1CYP1A2CYP3A4CYP1B1CYP2E1
SCHEMBL18152 0.78 NFE2L2 (0.53) CA1CA2CA9ACHE
SCHEMBL5542543 0.75 CYP1A1 (0.80) CYP1A1CYP1A2CYP3A4CYP1B1CYP2E1
SCHEMBL5632975 0.74 CYP1A1 (0.79) CYP1A1CYP1A2CYP3A4CYP1B1CYP2E1
SCHEMBL4167549 0.74 CYP1A2 (0.67) CYP1A1CYP1A2CYP3A4CYP1B1CYP2E1
SCHEMBL5542539 0.74 CYP1A1 (0.77) CYP1A1CYP1A2CYP3A4CYP1B1CYP2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2718264-B1 BENZOCYCLOHEPTENE ACETIC ACIDS HOFFMANN LA ROCHE (CH) 2015-08-05 — — EP disclosed
EP-2718264-A1 BENZOCYCLOHEPTENE ACETIC ACIDS F.HOFFMANN-LA ROCHE AG (CH) 2014-04-16 — — EP disclosed
CN-103596925-A Benzocycloheptene acetic acids HOFFMANN LA ROCHE 2014-02-19 — — CN disclosed
WO-2012168162-A1 BENZOCYCLOHEPTENE ACETIC ACIDS F. HOFFMANN-LA ROCHE AG (CH) 2012-12-13 — — WO disclosed
US-20120309796-A1 BENZOCYCLOHEPTENE ACETIC ACIDS FIROOZNIA FARIBORZ (US) 2012-12-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309796-A1 BENZOCYCLOHEPTENE ACETIC ACIDS ACAT2, ACAT1, CYP27A1 CYP1A1 25/4885CYP1A2 45/4885CYP3A4 134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback